| RS531887279 |
GFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS531893337 |
VPS37A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 53, Hereditary spastic paraplegia |
| RS531905447 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Inborn genetic diseases |
| RS531916765 |
ADPRS
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration, childhood-onset |
| RS531930335 |
FOLR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral folate transport deficiency, Cerebral folate transport deficiency |
| RS531930614 |
COL17A1
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta - hypoplastic autosomal dominant - local, Amelogenesis imperfecta - hypoplastic autosomal dominant - local |
| RS531932249 |
CREB3L3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS531935195 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS531943246 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, See cases |
| RS531944041 |
SPTA1
|
Health Risk |
Likely pathogenic |
— |
| RS531947687 |
HPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 1, Hermansky-Pudlak syndrome 1 |
| RS531949723 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS531965733 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS531970883 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Rothmund-Thomson syndrome type 2 |
| RS531972155 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
PIEZO1-related disorder, Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema |
| RS531987102 |
PEX10
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS531991442 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type II, Citrin deficiency |
| RS531994517 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS532003876 |
GATAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 2B, Cardiovascular phenotype |
| RS532007026 |
NGLY1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation 1 |
| RS532007878 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, DNAH11-related disorder |
| RS532009022 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS532018719 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS532021673 |
ACTL9
|
Health Risk |
Pathogenic |
Spermatogenic failure 53, Spermatogenic failure 53 |
| RS532025477 |
SNCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinson Disease, Dominant |
| RS532034867 |
SYNJ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS532042443 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Robinow syndrome, Brachydactyly type B1 |
| RS532044975 |
SIN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532048791 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS532054402 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Cardiovascular phenotype |
| RS532057629 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2U, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS532058076 |
NDUFAF6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS532072204 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS532073330 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS532077176 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532091149 |
C2
|
Health Risk |
Conflicting classifications of pathogenicity |
Complement component 2 deficiency, Age related macular degeneration 14 |
| RS532098737 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS532101469 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia |
| RS532102837 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Tibial muscular dystrophy |
| RS532111320 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS532112751 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532127028 |
LMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lipase deficiency, combined |
| RS532134925 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS532137455 |
PHKG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXc, Inborn genetic diseases |
| RS532139907 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS532143625 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 5, Cardiovascular phenotype |
| RS532147114 |
SPRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
Legius syndrome, Cardiovascular phenotype |
| RS532151097 |
STAR
|
Health Risk |
Pathogenic |
— |
| RS532158398 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS532169644 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS532170807 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Somatotroph adenoma |
| RS532174786 |
SLC5A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 20, Neuronopathy |
| RS532178791 |
UBA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 44 |
| RS532187086 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532188689 |
ADGRG1
|
Health Risk |
Likely pathogenic |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS532190594 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS532203068 |
GJB2
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Autosomal dominant nonsyndromic hearing loss 3A |
| RS532203771 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS532217889 |
ALS2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS532221052 |
NLRP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532223684 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS532224704 |
SLC34A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive hypophosphatemic bone disease, Autosomal recessive hypophosphatemic bone disease |
| RS532225764 |
ASH1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532230312 |
PKLR
|
Health Risk |
Likely pathogenic |
— |
| RS532234200 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex with nail dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2Q |
| RS532242119 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS532244792 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS532245223 |
CLDN16
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hypomagnesemia, Inborn genetic diseases |
| RS532254032 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1Y, Hypertrophic cardiomyopathy 3 |
| RS532257048 |
PGAP3
|
Health Risk |
Likely pathogenic |
— |
| RS532261094 |
CACNA2D1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS532266535 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS532268197 |
CDHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Optic atrophy |
| RS532275192 |
GNPTG
|
Health Risk |
Conflicting classifications of pathogenicity |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS532281287 |
TACC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS532285449 |
MUSK
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS532289025 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, LRBA-related disorder |
| RS532290202 |
SLC12A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532292359 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS532292902 |
SLC34A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive hypophosphatemic bone disease, Autosomal recessive hypophosphatemic bone disease |
| RS532294036 |
LEPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to leptin receptor gene deficiency, Obesity due to leptin receptor gene deficiency |
| RS532294251 |
OTOGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532302075 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS532310992 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS532319219 |
TARDBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS |
| RS532325984 |
TRIM37
|
Health Risk |
Conflicting classifications of pathogenicity |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS532329476 |
UNC80
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532329866 |
FOXP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebellar vermis hypoplasia, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS532332781 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS532338576 |
IGLL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Agammaglobulinemia 2, autosomal recessive |
| RS532344479 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Age related macular degeneration 4 |
| RS532348840 |
HPS1
|
Health Risk |
Likely pathogenic |
— |
| RS532351874 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS532356676 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS532360713 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS532365422 |
ORC3
|
Health Risk |
Likely pathogenic |
ORC3-related disorder, ORC3-related disorder |
| RS532385139 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS532385451 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS532386334 |
AGRN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS532388240 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Bethlem myopathy 1A |